Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook

d compensation arrangements 1.0 0.6 0.9 0.4 --- --- --- --- Diluted weighted average common shares outstanding 118.8 117.7 118.5 117.5 ===== ===== ===== ===== (1) Includes accelerated depreciation charges.

The following table presents a reconciliation of reported net income for the three and six months ended June 30, 2009 and 2008 to adjusted EBITDA:

                                                                   Table 5
                            Watson Pharmaceuticals, Inc.
                        Adjusted EBITDA Reconciliation Table
                              (Unaudited; in millions)

                                              Three Months    Six Months
                                                 Ended           Ended
                                                June 30,        June 30,
                                              2009    2008    2009    2008
                                              ----    ----    ----    ----
    GAAP net income                          $53.0   $60.3  $102.1  $110.9
            Interest expense                   4.6     6.9     9.3    13.7
            Interest income                   (1.3)   (1.7)   (3.3)   (4.0)
            Provision for income taxes        37.6    35.5    68.5    66.7
            Depreciation (includes
             accelerated depreciation)        24.1    22.5    47.3    44.2
            Amortization                      22.1    20.2    43.9    40.4
                                              ----    ----    ----    ----
    EBITDA                                   140.1   143.7   267.8   271.9
                                             -----   -----   -----   -----
    Adjusted for:

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Today, ... Rice, former Seattle Seahawks wide receiver, announced the donation ... in timing with Brain Injury Awareness Month. In an ... injuries and the importance of brain health, Rice and ... field and the need to make brain health a ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles ... crimes, recently spoke on the radio to give his insights ... the Independent Journal Review radio show “The Right Mics” chose ... prosecutor and now as a criminal defense attorney would provide ... trial and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
(Date:3/3/2015)... While it is clear that the prospect ... Canadian drivers are signing up to UBI policies, more ... be enticed. Due to current regulations, the application of ... Its full capability is starting to be realised ... emergency breakdown services are at the top of the ...
(Date:3/3/2015)... 2015 DePuy Pinnacle hip lawsuits ... of the artificial hip system caused recipients to ... forward in the federal multidistrict litigation underway in ... to the most recent Master Case List issued ... Pinnacle hip replacement lawsuits are now pending in ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... Parents to Get Children Vaccinated, Despite Scare in ABC,s ... March of,Dimes and seven former directors of the U.S. ... not to be frightened of childhood,vaccines by the suggestion ... that the mercury-based preservative thimerosal -- which is no ...
... for small doses of Plavix in children under 2 , , ... anti-clotting drug clopidogrel (Plavix) can benefit children under age 2 ... astonished at how little of the drug they needed to ... a fifth of the amount that we were expecting," Dr. ...
... in US GAAP, TORONTO, Jan. 29 /PRNewswire-FirstCall/ - ... products and services to the global life,sciences markets, today ... first time under US GAAP. These filings include the ... the Canadian,Supplement to the annual MD&A., To assist ...
... This release is also available in Spanish . ... for many years on that using the safety belt on the ... warning with the use of such device in the front seats ... more reduced. , With such a situation on the table, the ...
... Mayo Clinic ... physician, ... caregivers, and healthcare professionals can now register,for "Inflammatory Bowel Disease: Why ... Crohn,s & Colitis,Foundation will take place on Thursday, March 6, from ...
... of,Directors of BD (Becton, Dickinson and Company) (NYSE: ... per common share. The dividend will be,payable on March ... 2008. The,indicated annual dividend rate is $1.14 per share., ... technology company that manufactures and,sells medical devices, instrument systems ...
Cached Medicine News:Health News:Childhood Vaccines Save Lives, March Of Dimes Says 2Health News:Childhood Vaccines Save Lives, March Of Dimes Says 3Health News:Anti-Clotting Drug Helps Infants With Heart Ills 2Health News:Using the safety belt in the rear seats of the car reduces death risk by almost a half 2Health News:Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals 2
(Date:3/3/2015)...  This industry report package offers the most up-to-date market data on ... the world and in the top 10 global countries. Along with a ... following countries: Australia , China ... Italy , Japan , ... , United States The reports ...
(Date:3/3/2015)... PARK, Calif. , March 3, 2015  BioPharmX ... the development of novel drug delivery products to address ... announced that Jim Pekarsky , chief executive officer ... th Annual Roth Capital Partners Conference on Wednesday, ... Laguna Niguel in ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research and ... addition of the "Global POC Diagnostics Market 2015-2019" ... The analysts forecast the Global POC Diagnostics market to ... period 2014-2019. POC diagnostics are IVD ... outside a clinical laboratory setting. The use of these ...
Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... Wis., Sept. 16 Top researchers at the Gastrointestinal ... Dallas are exploring the clinical applications of BCM-95®, a ... bioavailability. Previous studies have shown that ... forms of curcumin, and had a retention time in ...
... Mich., Sept. 16 Metabolic Solutions Development Company (MSDC), ... Association for the Study of Diabetes (EASD) annual conference ... indicates that the company,s clinical candidate, MSDC-0160, promotes the ... to the creation of more brown fat.  The research ...
Cached Medicine Technology:BCM-95 Demonstrates Superior Anti-Inflammatory Effects 2Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, High Waist, Mid-thigh...
Uniform compression and support after multiple procedures. No uncomfortable waist band....
A One Piece Support Garment - any length or size...
Medicine Products: